Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
GEN’s Hall of Shame
GEN recently published a list called the “GEN Hall of Shame”, consisting of five U.S. Representatives and five U.S. Senators who have spearheaded efforts in recent years to reduce funds for federal agencies involved in funding basic research, sought to reverse individual NIH grant funding decisions, or, more recently, sought to narrow the activities of the agencies in ways that would alter their missions by Congressional vote. Will this list affect the way you cast your vote when the next election year rolls around?